The role of tumor-infiltrating immune cells, particularly CD8+ T cells and CD68+ macrophages, has been established as a significant factor in the prognosis of various cancers, including NSCLC [16,17]. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.